Back to User profile » Dr David Callanan

Papers published by Dr David Callanan:

Clinical Trial Report

Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results

Callanan D, Khurana RN, Maturi RK, Patel S, Wykoff CC, Eichenbaum D, Khanani AM, Hassan T, Badger H, Mehta S, Le G, Attar M, Seal J, Li XY

Clinical Ophthalmology 2023, 17:1367-1384

Published Date: 11 May 2023

Original Research

A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration

Williams PD, Callanan D, Solley W, Avery RL, Pieramici DJ, Aaberg T

Clinical Ophthalmology 2012, 6:1519-1525

Published Date: 17 September 2012

Review

The role of difluprednate ophthalmic emulsion in clinical practice

Karim N Jamal, David G Callanan

Clinical Ophthalmology 2009, 3:381-390

Published Date: 29 June 2009

Original Research

Topical nepafenac in the treatment of diabetic macular edema

David Callanan, Patrick Williams

Clinical Ophthalmology 2008, 2:689-692

Published Date: 5 December 2008